These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12053426)

  • 41. Development of health technology assessment in Europe. A personal perspective.
    Jonsson E
    Int J Technol Assess Health Care; 2002; 18(2):171-83. PubMed ID: 12053417
    [No Abstract]   [Full Text] [Related]  

  • 42. Collaboration in health technology assessment (EUnetHTA joint action, 2010-2012): four case studies.
    Huić M; Nachtnebel A; Zechmeister I; Pasternak I; Wild C
    Int J Technol Assess Health Care; 2013 Jul; 29(3):323-30. PubMed ID: 23759333
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ANALYSIS OF DUPLICATION AND TIMING OF HEALTH TECHNOLOGY ASSESSMENTS ON MEDICAL DEVICES IN EUROPE.
    Hawlik K; Rummel P; Wild C
    Int J Technol Assess Health Care; 2018 Jan; 34(1):18-26. PubMed ID: 29258630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health technology assessment.
    Kearney B
    J Qual Clin Pract; 1996 Sep; 16(3):131-43. PubMed ID: 8887856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European Union: Royal Society helps guide Brexit science.
    Maxton J
    Nature; 2016 Aug; 536(7616):274. PubMed ID: 27535524
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment and regulation of health care technology. The Dutch experience.
    Boer A
    Int J Technol Assess Health Care; 1999; 15(4):638-48. PubMed ID: 10645105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piloting international production of rapid relative effectiveness assessments of pharmaceuticals.
    Kleijnen S; Pasternack I; Rannanheimo P; Vuola JM; Van de Casteele M; Bucsics A; Pulis IZ; Di Bidino R; Sacchini D; Montilla S; Abrishami P; Sammut SM; Muscolo LA; Happonen P; Goettsch WG
    Int J Technol Assess Health Care; 2014 Nov; 30(5):521-9. PubMed ID: 25747562
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health technology assessment for medical devices in Europe. What must be considered.
    Siebert M; Clauss LC; Carlisle M; Casteels B; de Jong P; Kreuzer M; Sanghera S; Stokoe G; Trueman P; Lang AW;
    Int J Technol Assess Health Care; 2002; 18(3):733-40. PubMed ID: 12391964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A program proposal for new technology assessment.
    Whittenburg C
    AORN J; 1995 Feb; 61(2):391-2, 395-9. PubMed ID: 7717702
    [TBL] [Abstract][Full Text] [Related]  

  • 50. European Collaboration in Health Technology Assessment (HTA): goals, methods and outcomes with specific focus on medical devices.
    Erdös J; Ettinger S; Mayer-Ferbas J; de Villiers C; Wild C
    Wien Med Wochenschr; 2019 Sep; 169(11-12):284-292. PubMed ID: 30725440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pacific island partnership: the Pacific Cancer Initiative.
    Palafox NA; Gunawardane K; Demei Y
    J Cancer Educ; 2006; 21(1 Suppl):S87-90. PubMed ID: 17020508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Technology acquisition in Canadian hospitals: how are we doing?
    Deber R; Wiktorowicz M; Leatt P; Champagne F
    Healthc Manage Forum; 1995; 8(2):23-8. PubMed ID: 10144218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health technology assessment: research trends and future priorities in Europe.
    Nielsen CP; Funch TM; Kristensen FB
    J Health Serv Res Policy; 2011 Jul; 16 Suppl 2():6-15. PubMed ID: 21737525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relative effectiveness and the European pharmaceutical market.
    Jönsson B
    Eur J Health Econ; 2011 Apr; 12(2):97-102. PubMed ID: 21267624
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of the Canadian Coordinating Office for Health Technology Assessment.
    Battista RN; Feeny DH; Hodge MJ
    Int J Technol Assess Health Care; 1995; 11(1):102-16. PubMed ID: 7706007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019.
    Inotai A; Németh B
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):379-381. PubMed ID: 31159614
    [No Abstract]   [Full Text] [Related]  

  • 57. Comparing the hta core model with a national health technology assessment report.
    Pasternack I; de Groot I; Kleijnen S; Polman P
    Int J Technol Assess Health Care; 2014 Nov; 30(5):530-5. PubMed ID: 25747563
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The International Network of Agencies for Health Technology Assessment (INAHTA) or the need for collaboration in evaluating health technologies].
    Asua Batarrita J
    Med Clin (Barc); 1999; 112 Suppl 1():86-9. PubMed ID: 10618805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new information exchange system for nursing professionals to enhance patient safety across Europe.
    Stievano A; Jurado MG; Rocco G; Sasso L
    J Nurs Scholarsh; 2009; 41(4):391-8. PubMed ID: 19941585
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Report from the EUR-ASSESS Project.
    Werkö L; Banta D
    Int J Technol Assess Health Care; 1995; 11(4):797-9. PubMed ID: 8567214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.